Trial intelligence / Profile preview

CANVAS 1: Ceftaroline in cSSSI

NCT00424190Phase 3Completed

Sponsor
Forest Laboratories
Start
Feb 2007
Primary completion
Nov 2007
Modality
Small Molecules
Countries
11
01

Overview

A Phase 3 trial of ceftaroline fosamil in Complicated skin and skin structure infection (cSSSI), sponsored by Forest Laboratories. Started Feb 2007; status: completed.

02

Drugs

ceftaroline fosamil
03

Conditions

Complicated skin and skin structure infection (cSSSI)

Beyond the preview

Go deeper on NCT00424190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00424190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call